Next Generation News and Research

RSS

IVAX Diagnostics net revenues decrease 0.4% to $4,375,000 for quarter ended June 30, 2011

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended June 30, 2011.

23 Aug 2011

A CRADA for prostate disease research

Genomatix Software, the Uniformed Service University of the Health Sciences (USU), and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) have entered into a Cooperative Research and Development Agreement (CRADA) to extend their collaborative endeavors in prostate disease research.

22 Aug 2011

Medicinal Genomics sequences entire genomes of two therapeutic Cannabis strains

Medicinal Genomics, a private company headquartered in Marblehead, Mass., USA and the Netherlands, announced today that it has sequenced the entire genomes of Cannabis sativa and Cannabis indica, representing two strains of the therapeutic plant.

19 Aug 2011

Maternal stress may disrupt masculinization of developing mouse brain

Sons of male mice exposed to prenatal stress are more sensitive to stress as adults, according to a study in the August 17 issue of The Journal of Neuroscience. These findings suggest experiences in the womb can lead to individual differences in stress response that may be passed across generations.

18 Aug 2011

PAREXEL recognized as Company of the Year for the Pharmaceutical Industry

PAREXEL International Corporation, a leading global biopharmaceutical services provider, has been named Company of the Year for the Pharmaceutical Industry in The Eighth Annual International Business Awards, the only global, all-encompassing business awards program honoring great performances in business.

From Parexel 17 Aug 2011

Young stressed females can impair future offspring, also improve resilience

The study found that stress experienced by young female rats can impair their future offspring, but can also improve resilience. The study also showed that providing the young stressed females with an enriched environment, can indeed ameliorate some of the effects.

17 Aug 2011

PERCH study to look at current and likely future causes of childhood pneumonia

Pneumonia kills more children around the world than any other disease, but the last major effort to study the causes of childhood pneumonia across many countries was conducted in the 1980's. This week, a groundbreaking new study called the Pneumonia Etiology Research for Child Health (PERCH) study gets off the ground.

17 Aug 2011

Curis initiates CUDC-101 Phase I combination trial in advanced head and neck cancer

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the first patient has been treated in a Phase I combination trial of CUDC-101.

17 Aug 2011

Kineta's next generation antiviral program receives $2.8 million NIH SBIR grant

Kineta, Inc. announced today its next generation antiviral program has received a 2.8 million dollar grant from the National Institute of Allergy and Infectious Disease, a part of the National Institutes of Health (NIH). Awarded under the Small Business Innovation Research (SBIR) program, the prestigious phase two grant will provide on-going support for Kineta's work on a new class of antiviral drugs targeting an array of global, deadly viruses.

12 Aug 2011

Advaxis completes ADXS-PSA prostate cancer construct pre-IND meeting with the FDA

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed a pre-IND (Investigational New Drug) meeting with the FDA on August 10 to discuss the development plan for ADXS-PSA, a construct for the treatment of prostate cancer.

12 Aug 2011

Bovie Medical second quarter revenues increase 16% to $6.8 million

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the second quarter and six months ended June 30, 2011.

12 Aug 2011

LifeCodexx, Sequenom partner to commercialize prenatal lab testing services in Europe

Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced it has partnered with LifeCodexx AG, a company focused on the development of clinically validated Next Generation Molecular Diagnostics, for the commercialization of prenatal laboratory testing services in Europe.

11 Aug 2011

Israeli OCS approves $1.7M grant to support PROLOR's hGH-CTP program

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the Israeli Office of the Chief Scientist (OCS) has approved a 2011 grant to PROLOR's Israeli-based R&D subsidiary for the company's development program for hGH-CTP, its long-acting version of human growth hormone.

10 Aug 2011

TrovaGene regains ownership of worldwide rights to transrenal technology

TrovaGene, Inc., a developer of transrenal molecular diagnostics, confirmed today that it regained ownership of its worldwide rights and control over its patent estate for transrenal technology for non-invasive prenatal applications and cancer through the termination of a license agreement between TrovaGene and Sequenom, Inc.

10 Aug 2011

Hydros-TA therapy provides next generation of osteoarthritis relief

Osteoarthritis (OA) is the most common form of arthritis, affecting roughly 10% of Canadians. This degradation of the joints is painful and crippling, especially when it affects the knee. Although there are viable OA treatment options, they are short-lived and can have serious side-effects.

10 Aug 2011

GE Healthcare receives FDA clearance for Optima CT660 system

GE Healthcare today announced FDA clearance of Optima CT660 - a powerful and compact Computed Tomography (CT) system offering improvements from its predecessors in diagnostic capabilities at low dose levels, and designed for sustainability and ease-of-use.

9 Aug 2011

Affymetrix announces commercialization of next-generation human transcriptome array

Affymetrix, Inc. today announced commercialization of the next-generation human transcriptome array demonstrated by Stanford University researchers to be superior to mRNA sequencing (RNA-Seq) in gene expression profiling studies.

8 Aug 2011

Clinical warning system that uses wireless sensors can track vital signs of at-risk patients

A clinical warning system that uses wireless sensors to track the vital signs of at-risk patients is undergoing a feasibility study at Barnes-Jewish Hospital in St. Louis.

5 Aug 2011

Study stresses importance of broad-spectrum sunscreen to help prevent skin cancer

With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.

5 Aug 2011

Micromet second quarter total revenues increase to $7.1 million

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the second quarter and six months ended June 30, 2011.

4 Aug 2011

Next Generation News and Research

IVAX Diagnostics net revenues decrease 0.4% to $4,375,000 for quarter ended June 30, 2011

A CRADA for prostate disease research

Medicinal Genomics sequences entire genomes of two therapeutic Cannabis strains

Maternal stress may disrupt masculinization of developing mouse brain

PAREXEL recognized as Company of the Year for the Pharmaceutical Industry

Young stressed females can impair future offspring, also improve resilience

PERCH study to look at current and likely future causes of childhood pneumonia

Curis initiates CUDC-101 Phase I combination trial in advanced head and neck cancer

Kineta's next generation antiviral program receives $2.8 million NIH SBIR grant

Advaxis completes ADXS-PSA prostate cancer construct pre-IND meeting with the FDA

Bovie Medical second quarter revenues increase 16% to $6.8 million

LifeCodexx, Sequenom partner to commercialize prenatal lab testing services in Europe

Israeli OCS approves $1.7M grant to support PROLOR's hGH-CTP program

TrovaGene regains ownership of worldwide rights to transrenal technology

Hydros-TA therapy provides next generation of osteoarthritis relief

GE Healthcare receives FDA clearance for Optima CT660 system

Affymetrix announces commercialization of next-generation human transcriptome array

Clinical warning system that uses wireless sensors can track vital signs of at-risk patients

Study stresses importance of broad-spectrum sunscreen to help prevent skin cancer

Micromet second quarter total revenues increase to $7.1 million

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News